CG
CRBP icon

Cutler Group’s Corbus Pharmaceuticals CRBP Stock Holding History

Cutler Group’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$31K Buy
+800
New +$19.7K 0.01% 856
2023
Q2 		– Sell
-353
Closed -$2K – 3658
2023
Q1 		$2K Hold
353
– – ﹤0.01% 3106
2022
Q4 		$1K Hold
353
– – ﹤0.01% 3956
2022
Q3 		$1K Hold
353
– – ﹤0.01% 4468
2022
Q2 		$2K Hold
353
– – ﹤0.01% 4247
2022
Q1 		$5K Hold
353
– – ﹤0.01% 4100
2021
Q4 		$6K Hold
353
– – ﹤0.01% 4044
2021
Q3 		$10K Hold
353
– – ﹤0.01% 3908
2021
Q2 		$19K Hold
353
– – ﹤0.01% 3333
2021
Q1 		$20K Hold
353
– – ﹤0.01% 3200
2020
Q4 		$13K Sell
353
-127
-26% -$4.75K ﹤0.01% 2976
2020
Q3 		$25K Buy
+480
New +$86.9K ﹤0.01% 2280
2019
Q1 		– Sell
-42
Closed -$7K – 4123
2018
Q4 		$7K Sell
42
-9
-18% -$1.8K ﹤0.01% 2723
2018
Q3 		$11K Buy
+51
New +$8.24K ﹤0.01% 2585
2018
Q2 		– Sell
-180
Closed -$32K – 4279
2018
Q1 		$32K Sell
180
-232
-56% -$52.1K ﹤0.01% 1962
2017
Q4 		$87K Buy
412
+359
+677% +$76.8K ﹤0.01% 1467
2017
Q3 		$11K Sell
53
-252
-83% -$49.3K ﹤0.01% 3703
2017
Q2 		$57K Buy
305
+76
+33% +$14.9K ﹤0.01% 2356
2017
Q1 		$56K Sell
229
-196
-46% -$48.1K ﹤0.01% 2294
2016
Q4 		$107K Buy
425
+392
+1,188% +$89.9K ﹤0.01% 1849
2016
Q3 		$6K Buy
+33
New +$4.11K ﹤0.01% 4739

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Cutler Group's CRBP Position: Q1 2024 in Review

Cutler Group opened a new position in Corbus Pharmaceuticals (CRBP) in Q1 2024: 800 shares worth $31K. The stake represents 0.01% of the portfolio and ranks #856 among its holdings. This is a return to the name: Cutler Group previously reported a position in CRBP as recently as Q1 2023.

Cutler Group first reported a position in CRBP in Q3 2016 and has held it in 21 quarters since. The position peaked at $107K in Q4 2016. 82 funds tracked by Wall St. Rank hold CRBP as of Q1 2024.

  • Cutler Group held 800 shares of Corbus Pharmaceuticals worth $31K as of Q1 2024.
  • Corbus Pharmaceuticals was a new Cutler Group position in Q1 2024.
  • Corbus Pharmaceuticals made up 0.01% of Cutler Group's portfolio in Q1 2024, its #856 holding.
  • Cutler Group first reported a position in Corbus Pharmaceuticals in Q3 2016 and has held it in 21 quarters since.
  • Cutler Group's Corbus Pharmaceuticals position peaked at $107K in Q4 2016.
  • 82 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.